Basic Information
| RNALocate ID: | RLID:11004418 |
| RNA Symbol: | hsa-miR-365a-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-365a-5p |
| RNA ID: | miRBase:MIMAT0009199 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002819 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01002820 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:11004419 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000812 | Microvesicle | Fibroblasts|Mesenchymal stem cells | |
| RLID-D:11001770 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-365a-5p | Gastric cancer | MNDR-E-MI-44272 |
| MNDR | hsa-miR-365a-5p | Intracranial aneurysm | MNDR-E-MI-44273 |
| MNDR | hsa-miR-365a-5p | Parkinson disease | MNDR-E-MI-44274 |
| MNDR | hsa-miR-365a-5p | West nile virus infection | MNDR-E-MI-44275 |
| MNDR | hsa-miR-365a-5p | Carcinoma ductal breast | MNDR-E-MI-44276 |
| MNDR | hsa-miR-365a-5p | Lung squamous cell carcinoma | MNDR-E-MI-44277 |
| MNDR | hsa-miR-365a-5p | Lung adenocarcinoma | MNDR-E-MI-44278 |
| MNDR | hsa-miR-365a-5p | Carcinoma renal cell | MNDR-E-MI-44279 |
| MNDR | hsa-miR-365a-5p | Cholangiocarcinoma | MNDR-E-MI-44280 |
| MNDR | hsa-miR-365a-5p | Esophageal cancer | MNDR-E-MI-44281 |
| MNDR | hsa-miR-365a-5p | Stomach carcinoma | MNDR-E-MI-44282 |
| MNDR | hsa-miR-365a-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-44283 |
| MNDR | hsa-miR-365a-5p | Breast invasive carcinoma | MNDR-E-MI-44284 |
| MNDR | hsa-miR-365a-5p | Hepatocellular carcinoma | MNDR-E-MI-44285 |
| MNDR | hsa-miR-365a-5p | Skin cutaneous melanoma | MNDR-E-MI-44286 |
| MNDR | hsa-miR-365a-5p | Skin melanoma | MNDR-E-MI-44287 |
| MNDR | hsa-miR-365a-5p | Colorectal cancer | MNDR-E-MI-44288 |
| MNDR | hsa-miR-365a-5p | Nasopharynx carcinoma | MNDR-E-MI-44289 |
| MNDR | hsa-miR-365a-5p | Nasopharyngeal cancer | MNDR-E-MI-44290 |
TOP